4//SEC Filing
Vaccinex (Rochester), L.L.C. 4
Accession 0000891839-19-000038
CIK 0001205922other
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 4:30 PM ET
Size
14.3 KB
Accession
0000891839-19-000038
Insider Transaction Report
Form 4
VACCINEX, INC.VCNX
Vaccinex (Rochester), L.L.C.
10% Owner
Transactions
- Purchase
Common Stock
2019-03-14$4.00/sh+1,000$4,000→ 4,789,469 total(indirect: By FCMI Parent Co.) - Purchase
Common Stock
2019-03-15$3.96/sh+1,000$3,960→ 4,790,469 total(indirect: By FCMI Parent Co.)
Holdings
- 439,555
Common Stock
- 583,333(indirect: By Global Macro Hedge Fund Ltd.)
Common Stock
- 9,679,833(indirect: By FCMI Financial Corporation)
Option (Right to Acquire)
→ Common Stock (967,983 underlying) - 37,633(indirect: By Trust)
Common Stock
- 21,475,000(indirect: By FCMI Parent Co.)
Option (Right to Acquire)
→ Common Stock (1,180,051 underlying)
FRIEDBERG ALBERT
Director10% Owner
Transactions
- Purchase
Common Stock
2019-03-14$4.00/sh+1,000$4,000→ 4,789,469 total(indirect: By FCMI Parent Co.) - Purchase
Common Stock
2019-03-15$3.96/sh+1,000$3,960→ 4,790,469 total(indirect: By FCMI Parent Co.)
Holdings
- 37,633(indirect: By Trust)
Common Stock
- 439,555
Common Stock
- 21,475,000(indirect: By FCMI Parent Co.)
Option (Right to Acquire)
→ Common Stock (1,180,051 underlying) - 583,333(indirect: By Global Macro Hedge Fund Ltd.)
Common Stock
- 9,679,833(indirect: By FCMI Financial Corporation)
Option (Right to Acquire)
→ Common Stock (967,983 underlying)
Footnotes (7)
- [F1]Mr. Friedberg is the majority owner of Pan Atlantic Bank & Trust Ltd. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- [F2]Mr. Friedberg possesses voting and dispositive power over the reported securities and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- [F3]The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019.
- [F4]Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- [F5]Partnership interests in VX3 (DE) LP, or VX3, which are exchangeable into shares of Common Stock on a 1-for-0.05495 basis at the holder's option. On August 13, 2018, FCMI Parent Co. entered into an exchange agreement with the Issuer and the other partners of VX3 that provides each VX3 partner the right to exchange all, but not less than all, of its partnership interests in VX3 for shares of Common Stock. The option has no expiration date.
- [F6]Limited partnership units of Vaccinex Products, LP, which are exchangeable into shares of Common Stock on a 1-for-10 basis at the holder's option.
- [F7]FCMI Financial Corp. is a wholly-owned subsidiary of FCMI Parent Co. Mr. Friedberg disclaims beneficial ownership of these shares except to the extent of his pecuniary interests therein.
Documents
Issuer
VACCINEX, INC.
CIK 0001205922
Entity typeother
IncorporatedGA
Related Parties
1- filerCIK 0001747866
Filing Metadata
- Form type
- 4
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 4:30 PM ET
- Size
- 14.3 KB